AVIR Green Hills Biotechnology AG

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults